My research was never merely papers published to stack shelves in academic libraries; it was a relentless attempt to decode the "language of cells" and harness it to serve humanity. My research school was founded on a unique holistic vision that integrates the rigor of engineering with the complexity of biology, adopting a flexible methodology that pairs quantitative statistical analysis for tracking variables with qualitative research to explore subtle cellular behaviors in their most precise manifestations.
It was my destiny to be among the first to observe the phenomenon of "programmed cell death" (apoptosis) in cultured cells—a fundamental discovery that radically shifted our understanding of the physiology of life and death at the cellular level, not only in laboratories, but across all biotechnology sectors. I did not stop at theoretical discovery; I employed genetic engineering tools to develop cell lines possessing "genetically extended longevity" and a superior ability to resist destruction, rendering them more resilient and productive inside bioreactors. This innovation was not purely technical; it held a profound economic and humanitarian dimension, contributing to raising the production efficiency of therapeutic proteins and vaccines while lowering costs to bring them within reach of those in greatest need.
My constant ambition was to transition from "prediction" to "certain vision" of what occurs inside the cell at the exact moment it happens. Thus, I gave back to the scientific field by pioneering monitoring techniques using "flow cytometry." This technique, which allowed us to observe cell viability and responses to drugs and toxins moment by moment, has today become the global standard in the bioprocess industry and an indispensable tool for ensuring precision in producing biological vaccines, such as polio and avian flu vaccines.
Yet the project closest to my heart remains those artificial biosystems that touched the edge of science fiction before we turned them into tangible reality. I took on the challenge of developing a "bioartificial liver" to perform complex metabolic and physiological functions, serving as a lifeline for liver failure patients seeking a second chance. This legacy extends to include my pioneering research in producing artificial red blood cells and engineering knee cartilage, opening unprecedented horizons in regenerative medicine.
This journey, with all its innovations in 3D environments and dielectrophoresis techniques, would not have been complete without my role as an educator and mentor. Grounding rigorous research questions and passing on scientific methodology to generations of scientists and engineers was my truest and purest investment. I instilled in them that engineering is not merely dry equations or mute designs, but the highest tool for decoding life and crafting hope for a healthier future for humanity.
The Price of Wisdom
With more than 500 research papers and patents, the Cell Engineering book series, and the supervision of hundreds of theses, I stand today looking back. The road was not easy; it was a continuous lesson in cooperation to reap greater rewards.
And as Naguib Mahfouz said: "Life gives free lessons to no one; when I say life taught me, be certain that I paid the price." As for me, I paid the price out of love for science, and in loyalty to a homeland to which I returned in 2003, laden with all this legacy.
